Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer.
Clinical trial NCT04212026 · TERMINATED
Trial details
- NCT number
- NCT04212026
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-28
- Primary completion
- 2023-07-12
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.